Value in Health

Title Publication Date Language Citations
Negative Drug Pricing in the Context of Cost-Effectiveness Analysis: A Consistency Examination2024/01/01English
Section 50 of the Inflation Reduction Act Drug Price Negotiation Program: Considerations for the Centers for Medicare & Medicaid Services, Manufacturers, and the Health Economics and Outcomes Research Community2023/12/01English
Appropriate Categorization of Inequality to Inform Policy Decisions: Estimating Distribution of Lifetime Health Using Alternative Approaches to Socioeconomic Stratification2024/01/01English
Testing 2 Alternative Time Trade-Off Methods for Valuation of Children’s Health States2024/01/01English
Toward Patient-Centered Drug Approval for Treatment of Rare Diseases2024/03/01English
Do Quality-Adjusted Life-Years Discriminate Against the Elderly? An Empirical Analysis of Published Cost-Effectiveness Analyses2024/03/01English
Anti–Vascular Endothelial Growth Factor Drugs Compared With Panretinal Photocoagulation for the Treatment of Proliferative Diabetic Retinopathy: A Cost-Effectiveness Analysis2024/03/01English
Challenges of Incorporating Life Cycle Drug Pricing in Cost-Effectiveness Models: A Review of Methods and Modeling Suggestions2024/03/01English
Development of a Value Assessment Framework for Pediatric Health Technologies Using Multicriteria Decision Analysis: Expanding the Value Lens for Funding Decision Making2024/03/01English
Logical Inconsistencies with Expected Utility Theory May Align Better With Patient Preferences—A Response to Paulden et al2024/03/01English
The Measurement Properties of the EQ Health and Well-being and EQ Health and Well-Being Short Form in Italian Population: A Comparative Study With EQ-5D-5L2024/03/01English
Comparison of EQ Health and Well-Being Long and Short With Other Preference-Based Measures Among United States Informal Caregivers2024/03/01English
Cost-effectiveness of 2 Models of Pessary Care for Pelvic Organ Prolapse: Findings From the TOPSY Randomized Controlled Trial2024/03/01English
Psychometric Properties of General Oral Health Assessment Index Across Ages: COSMIN Systematic Review2024/03/01English
Hepatitis C Elimination in Rwanda: Progress, Feasibility, and Economic Evaluation2024/03/01English
Flexible Approaches Based on Multistate Models and Microsimulation to Perform Real-World Cost-Effectiveness Analyses: An Application to Proprotein Convertase Subtilisin-Kexin Type 9 Inhibitors2024/03/01English
Methods for Including Adverse Events in Economic Evaluations: Suggestions for Improvement2024/03/01English
Tackling Challenges in Assessing the Economic Value of Tumor-Agnostic Therapies: A Cost-Effectiveness Analysis of Pembrolizumab as a Case Study2024/03/01English
Deriving Meaningful Aspects of Health Related to Physical Activity in Chronic Disease: Concept Elicitation Using Machine Learning–Assisted Coding of Online Patient Conversations2023/07/01English
Copyright/Subscription2023/03/01English
Editorial Board2023/03/01English
Table of Contents2023/03/01English
Table of Contents2023/04/01English
Editorial Board2023/04/01English
Copyright/Subscription2023/04/01English
Reviewer Acknowledgment2023/04/01English
Targeting Diabetes Prevention to More Disadvantaged Groups Improves Cost-Effectiveness: Implications of Inequality in Type 2 Diabetes From Theoretical Interventions2023/07/01English
Table of Contents2024/02/01English
Drug Pricing, Patient Welfare, and Cost-Effectiveness Analysis2024/03/01English
A Comparison of Items and Constructs of Standardized Health-Related Quality of Life and Mental Well-Being Measures2024/04/01English